Mirum Pharmaceuticals Inc Stock News
$70.97
2.62%
yesterday
Nasdaq,
Nov 21, 10:00 pm CET
Mirum Pharmaceuticals Inc Stock News
Neutral
Business Wire
●
11 days ago
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Neutral
Business Wire
●
15 days ago
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharma Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical Programs at AASLD's The Liver Meeting®.
Neutral
Seeking Alpha
●
18 days ago
Mirum Pharmaceuticals, Inc. ( MIRM ) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST Company Participants Andrew McKibben - Senior Vice President, Strategic Finance & Investor Relations Christopher Peetz - CEO & Director Peter Radovich - COO & President Joanne M. Quan - Chief Medical Officer Eric Bjerkholt - Chief Financial Officer Conference Call Participants Abdulqudus Tahlil - JPMorgan Ch...
Neutral
Business Wire
●
18 days ago
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update.
Neutral
Business Wire
●
19 days ago
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences.
Neutral
Business Wire
●
25 days ago
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025.
Neutral
Business Wire
●
about one month ago
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Neutral
Business Wire
●
2 months ago
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
